A dividend is more than passive income to investors. It’s a sign of confidence from management in the business itself. After all, management probably wouldn’t give you that cash to shareholders if they felt the company needed it more.
Do you know what’s better than a dividend? A rising dividend. Increasing the amount a company pays is the ultimate vote of confidence. These are the businesses you want to buy and hold.
Healthcare is a multitrillion-dollar industry, but a few familiar faces have excelled for decades — enough so that they’ve raised their dividends for 50 consecutive years or longer, making them Dividend Kings.
Here are three dividend-paying healthcare stocks you can buy and hold confidently today.
1. A company with a higher credit rating than America
Johnson & Johnson (JNJ) is arguably the bluest blue chip stock on Wall Street. The company has a history dating back to the 1800s and is still a fixture in the healthcare industry. After spinning off its consumer products segment as Kenvue, the business is even more focused on pharmaceutical products, medical devices, and technology.
Want consistency? From 1980 to 2020, Johnson & Johnson never saw annual sales dip more than 6% from their high.
Today, the stock yields a noteworthy 3% at its current share price. The stock trades at a forward P/E ratio of only 15. Admittedly, analysts are a little sour on Johnson & Johnson’s growth outlook, forecasting annual earnings growth of only 5% to 6% over the next three to five years. But ultimately, you’re paying for that consistency and quality. There might not be a better company to trust your money with.
2. This stock is a King in the medical device category
Becton, Dickinson (BDX) is another company that’s built a reputation for excellence over decades. It’s a highly diverse business that designs and sells medical supplies, equipment, and diagnostics tools to various healthcare users, including doctors, researchers, and hospitals. That means it doesn’t rely on any specific end market or user, making Becton, Dickinson a durable performer for investors.
The stock trades at 18 times estimated 2024 earnings, a reasonable valuation for a company analysts figure will grow earnings by over 9% annually for the next several years. Investors would be best served to plant Becton, Dickinson in a diversified portfolio and let the business continue to do what it’s already been doing for decades.
3. Buy and hold this diversified blue chip
Abbott Laboratories (ABT) is the definition of a wealth compounder. An employee named Grace Groner once bought a few shares of stock in the 1930s and held them until the day she passed away. Due to the company’s decades of steady growth, she died a multimillionaire.
Abbott Labs is a healthcare conglomerate that is still an industry force today. It sells consumer products, medical devices and equipment, and generic pharmaceuticals in emerging markets.
Abbott’s only knock is how much shares cost today. The stock’s forward P/E of 26 reflects the high esteem Wall Street holds it in, though analysts believe earnings growth will average 9% annually for the next three to five years. Abbott’s quality makes it hard to stay away, so consider a dollar-cost average strategy with Abbott. Buying a little at a time will leave you some dry powder in case market turbulence serves up shares at a more attractive valuation.
— Justin Pope
46-Year-Old CEO Bets $44.2 Billion on One Stock [sponsor]Netflix is NOT the future of entertainment. It's only a small fraction. And one billionaire CEO is taking charge of what Netflix DOESN'T do and leading the way for the next generation of entertainment. His forward-thinking company, which many people haven't even heard of yet, doesn't only want to compete with Netflix... It wants to rule the world...
Source: The Motley Fool
